Mobilization of myeloma cells involves SDF-1/CXCR4 signaling and downregulation of VLA-4

被引:49
作者
Gazitt, Y [1 ]
Akay, C [1 ]
机构
[1] Univ Texas, Hlth Sci Ctr, Dept Med Hematol, San Antonio, TX 78284 USA
关键词
myeloma; mobilization; SDF-1/CXCR4; VLA4;
D O I
10.1634/stemcells.22-1-65
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Adhesion molecules and stromal cell-derived factor-1 (SDF-1)/CXCR4 signaling play key roles in homing and mobilization of hematopoietic stem cells (HSC). Active signaling through SDF-1/CXCR4 and upregulation of adhesion molecules are required for homing, whereas downregulation of adhesion molecules and disruption of SDF-1/CXCR4 signaling are required for mobilization of HSC. We studied the surface expression of CXCR4 very late activation antigen (VLA)-4 and VLA-5 on myeloma cells mobilized with cyclophosphamide and GM-CSF in 12 multiple myeloma patients undergoing HSC mobilization for autologous transplantation. We also studied the plasma levels of SDF-1 in apheresis collection of these patients. We observed a statistically significant decrease in the levels of SDF-1 and surface expression of CXCR4 on myeloma cells in four consecutive apheresis collections compared with premobilization bone marrow specimens. We also observed a statistically significant decrease in surface expression of VLA-4 in myeloma cells in the apheresis collections compared with premobilization bone marrow samples. Furthermore, myeloma cells derived from apheresis collections had decreased adhesion and transstromal migration in response to SDF-1, which could be reversed by short incubation with interleukin-6. Hence, mobilization of myeloma cells involves SDF-1/CXCR4 signaling and downregulation of VLA-4.
引用
收藏
页码:65 / 73
页数:9
相关论文
共 61 条
[11]   Cell adhesion mediated drug resistance (CAM-DR): Role of integrins and resistance to apoptosis in human myeloma cell lines [J].
Damiano, JS ;
Cress, AE ;
Hazlehurst, LA ;
Shtil, AA ;
Dalton, WS .
BLOOD, 1999, 93 (05) :1658-1667
[12]  
Donnard M, 2002, BLOOD, V100, p349A
[13]  
DREYFUS F, 1995, BONE MARROW TRANSPL, V15, P707
[14]   Biological effects of stroma-derived factor-1α on normal and CML CD34+ haemopoietic cells [J].
Dürig, J ;
Rosenthal, C ;
Elmaagacli, A ;
Heyworth, C ;
Halfmeyer, K ;
Kasper, C ;
Novotny, J ;
Dührsen, U .
LEUKEMIA, 2000, 14 (09) :1652-1660
[15]   Differential expression of chemokine receptors in B cell malignancies [J].
Dürig, J ;
Schmücker, U ;
Dührsen, U .
LEUKEMIA, 2001, 15 (05) :752-756
[16]  
Förster R, 1998, J IMMUNOL, V160, P1522
[17]   Immunologic profiles of effector cells and peripheral blood stem cells mobilized with different hematopoietic growth factors [J].
Gazitt, Y .
STEM CELLS, 2000, 18 (06) :390-398
[18]   TRAIL is a potent inducer of apoptosis in myeloma cells derived from multiple myeloma patients and is not cytotoxic to hematopoietic stem cells [J].
Gazitt, Y .
LEUKEMIA, 1999, 13 (11) :1817-1824
[19]   Differential mobilization of myeloma cells and normal hematopoietic stem cells in multiple myeloma after treatment with cyclophosphamide and granulocyte-macrophage colony-stimulating factor [J].
Gazitt, Y ;
Tian, EM ;
Barlogie, B ;
Reading, CL ;
Vesole, DH ;
Jagannath, S ;
Schnell, J ;
Hoffman, R ;
Tricot, G .
BLOOD, 1996, 87 (02) :805-811
[20]   Successful PBSC mobilization with high-dose G-CSF for patients failing a first round of mobilization [J].
Gazitt, Y ;
Freytes, CO ;
Callander, N ;
Tsai, TW ;
Alsina, M ;
Anderson, J ;
Holle, L ;
Cruz, J ;
Devoer, P ;
McGrath, M ;
West, G ;
Alvarez, R ;
Montgomery, W .
JOURNAL OF HEMATOTHERAPY, 1999, 8 (02) :173-183